Stevanato Group, a global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, announced that it will begin construction on its new U.S. facility in Fishers, Indiana, this month. The site, expected to be operational in 2023, will enable Stevanato Group to be in closer proximity to its North America pharmaceutical customers and to provide an additional supply source for its mission critical products to serve customers better.
The Group expects to invest approximatively 145million USD to build and equip the manufacturing facility. The plant should be up to 370,000 square feet and will house state-of-the-art production lines equipped with advanced process technologies to produce EZ-Fill® syringes and vials.
In addition, Stevanato Group plans to use the new facility as a centre for after-sales support dedicated to serving its North America engineering customers, offering technical support as well as maintenance for visual inspection, assembly and packaging equipment.
The new Fishers plant is will enhance Stevanato Group’s North America footprint by allowing it to serve customers with an integrated approach, from design and development through commercialization. Stevanato Group plans to do this through the combined capabilities of its Technology Excellence Center based in Boston, offering scientific analytical capabilities; the Indiana EZ-Fill® hub, delivering drug containment solutions that drive real value; and its device manufacturing facility in California.
On September 23, 2021, Stevanato Group celebrated the new plant with a groundbreaking ceremony in Fishers attended by Indiana Governor Eric J. Holcomb, Fishers Mayor Scott Fadness, and other local guests.
“We are thrilled to begin construction on our new U.S. hub, and expand our presence in one of the fastest growing markets where we see increasing demand. We believe this will allow us to further enhance our services to our valued North America customers and underscores our desire to ensure supply chain security, just in time delivery and reliable sourcing in terms of surge capacity,” said Franco Moro, Stevanato Group Chief Executive Officer. “We are proud to join the Fishers community. This is an exciting achievement for our company, and we look forward to continuing to enable our customers – in the U.S. and around the world – to deliver safe and effective treatments to patients.”
Stevanato Group’s facility is expected to be part of a new pharmaceutical and life sciences park in Fishers, and the company intends to hire more than 230 new local employees by the end of 2025 for roles in production, engineering and maintenance, as well as other corporate support positions.